ConvaTec Group Plc
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$3.22
FAIR PRICE
$2.39
MARGIN
$0.83
NOW AVAILABLE
Get notified when CNVVF's fair price changes
Push notifications when CNVVF's valuation shifts. Available on iOS and Android.
FPI RATING
Stable earnings and revenue, but below-average fundamental quality and limited growth momentum.
Analytical data, not an investment recommendation. Updated daily.
How we calculate this ↗MARGIN OF SAFETY
A 20% margin of safety below fair value — the conservative entry level for risk-aware investors.
SAFETY MARGIN
20%
Below fair value
ENTRY LEVEL
$1.91
Fair price × 0.80
DISTANCE
40.6%
Price to entry level
At the current price of $3.22, CNVVF trades 40.6% above the conservative entry level of $1.91. This entry level represents a 20% margin of safety below the calculated fair price of $2.39 — a buffer that accounts for estimation uncertainty in the valuation model.
Margin of safety is a risk management concept, not an investment recommendation. The 20% threshold follows Benjamin Graham's value investing framework. Fair price and entry levels are model-based estimates updated daily. Learn more about Margin of Safety ↗
VALUATION HISTORY
Loading chart data...
P/E RATIO HISTORY
Loading chart data...
METHODOLOGY
How we calculate CNVVF's fair price
ConvaTec Group Plc's fair price of $2.39 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $3.22, CNVVF trades 25.8% above its calculated fair value.
DCF MODEL · 50%
Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting CNVVF's risk profile.
RELATIVE · 30%
Comparing CNVVF's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.
ANALYST · 20%
Aggregated analyst price targets for CNVVF, weighted by recency and analyst accuracy.
TRY IT YOURSELF
Want to test your own assumptions? Use our free calculators to estimate CNVVF's fair value with your own inputs.
LEARN MORE
POWERED BY BULIOS
Get full analysis, financials, and AI insights for CNVVF.
Explore on BuliosFAQ
What is the fair price of CNVVF?+
Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for ConvaTec Group Plc is $2.39. At the current market price of $3.22, CNVVF trades 25.8% above its calculated fair value.
Is CNVVF overvalued or undervalued?+
ConvaTec Group Plc is currently overvalued based on our valuation model. The stock trades at $3.22, which is 25.8% above the fair price of $2.39. The P/E ratio of 20.0x is a key metric in the valuation.
What is the margin of safety for CNVVF?+
With a 20% margin of safety applied to the fair price of $2.39, the conservative entry level for CNVVF is $1.91. At the current market price of $3.22, the stock trades 40.6% above this entry level. Margin of safety is a risk management concept from Benjamin Graham's value investing framework, not an investment recommendation.
How often is CNVVF's fair price updated?+
We update fair price calculations for CNVVF daily after market close. The current fair price of $2.39 incorporates the latest market data and sector multiples.
What factors affect CNVVF's fair price calculation?+
CNVVF's fair price of $2.39 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight). Key metrics include P/E of 20.0x, ROE of 19.5%, and dividend yield of 3.77%.
Is CNVVF a good buy right now?+
At $3.22, CNVVF trades 25.8% above our fair value estimate of $2.39. The stock is currently overvalued. ROE stands at 19.5% (strong). Fair Price Index provides valuation data — always do your own research before investing.
Does CNVVF pay dividends?+
CNVVF has a dividend yield of 3.77%.
RELATED STOCKS
Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.